Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • The Pharma 50

RCSB Protein Data Bank now has more than 1,000 SARS-CoV-2 proteins

By Brian Buntz | March 5, 2021

The fusion of SARS-CoV-2

Acknowledgement: Illustration by David S. Goodsell, RCSB Protein Data Bank; doi: 10.2210/rcsb_pdb/goodsell-gallery-026

The RCSB Protein Data Bank has announced that more than 1,000 SARS-CoV-2 proteins are available at no cost. 

Headquartered at Rutgers University–New Brunswick, the RCSB Protein Data Bank released its first SARS-CoV-2 structure — the coronavirus main protease (PDB 6lu7) — on Feb. 5, 2020. 

The database has helped drive the development of effective COVID-19 vaccines. It continues to shed light on emerging variants of the virus, according to Stephen K. Burley, director of the RCSB Protein Data Bank. “The impact of structural biologists on research related to COVID-19 is a testament to the power of the experimental tools they use and their commitment to making data open access for the public good,” Burley said in a statement.

The database also offers proteins related to other viral outbreaks, including Middle East Respiratory Syndrome (MERS). It could also help scientists “prepare better for when the next coronavirus jumps the species barrier to humans,” Burley said. 

In all, the Protein Data Bank contains more than 175,000 3D structures for proteins, DNA and RNA. 


Filed Under: Drug Discovery, Drug Discovery and Development, Genomics/Proteomics, Infectious Disease
Tagged With: coronavirus, covid-19, COVID-19 vaccine, COVID-19 vaccines, DNA, MERS, RCSB Protein Data Bank, RNA, SARS-CoV-2 proteins
 

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Related Articles Read More >

Lab facility
Massachusetts is competing for ARPA-H biomedical research center
Blockchain
Startup vies to get blockchain adoption in pharma off the ground
Black Diamond Therapeutics
Black Diamond analysis highlights 22 new oncogenic HER2 driver mutations
NIH National Institutes of Health
NIH licenses COVID-19 research technologies to WHO initiative

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • The Pharma 50